When a tiny lizard turned up at the edge of a proposed housing development outside Melbourne in 2023, it was the first ...
To this day, in the known universe, only one example exists of a system capable of general-purpose intelligence. That system ...
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and ...
As more HBS women freeze their eggs, the expanding trade in fertility and surrogacy forces the question: should everything be ...
Attachment to smart devices and biometric surveillance leaves Americans more vulnerable to police searches than ever. Left unchecked it will only get worse.
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient’s risk of hepatocellular carcinoma (HCC), the most common ...
Poodle crossbreeds have grown overwhelmingly popular, sparking controversy in dog parks and kennel clubs alike.
The Hearty Soul on MSN
New AI tool might predict pancreatic cancer risk years before diagnosis
Pancreatic cancer rarely announces itself early. It often grows in deep tissue, causes vague symptoms, and reaches medical ...
Kim Kardashian posted about it on Instagram and got 3.4 million likes. Bryan Johnson spends $2 million a year chasing it. And somewhere on London’s Harley Street, a year-long health optimization ...
Hosted on MSN
GeneDx (WGS), Zevra Therapeutics (ZVRA) partner to launch sponsored genetic testing program for NPC
GeneDx Holdings Corp. (NASDAQ:WGS) is one of the most promising stocks under $100 to buy. On March 10, GeneDx and Zevra Therapeutics (NASDAQ:ZVRA) announced a new partnership to launch a sponsored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results